Joyzyme Group Limited
8622.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$85.05M
Close$
$-0.04
126.1% downside
Current Fair Value
126.1% downsideOvervalued by 126.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $85.05 Million |
|---|---|
| Enterprise Value | $59.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 0.72 |
| Outstanding Shares | 515,472,000 |
Return
| Return on Equity | -10.32% |
|---|---|
| Return on Assets | -7.65% |
| Return on Invested Capital | -17.08% |
Valuation & Multiples
| P/E Ratio | -11.61 |
|---|---|
| PEG | -466.12 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.82 |
| Enterprise Value to EBIT | -6.96 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Joyzyme Group Limited
101 employees
CEO: Lai Yin Poon Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Re...